Activation and Detoxification of Naphthoquinones by NAD(P)H: Quinone Oxidoreductase

Methods in Enzymology

Volumn 382, Issue , 2004, Pages 364-380

  Munday, Rex ^a  

^a RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2,3 DIMETHOXY 1,4 NAPHTHOQUINONE; 2,3 DIMETHYL 1,4 NAPHTHOQUINONE; BETA LAPACHONE; HYDROQUINONE; JUGLONE; LAWSONE; MENADIONE; NAPHTHAZARIN; NAPHTHOQUINONE; OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RUFOCROMOMYCIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOOXIDATION; CHEMICAL REACTION KINETICS; CYTOTOXICITY; DETOXIFICATION; ENZYME ACTIVATION; MOLECULAR STABILITY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PURIFICATION; REACTION ANALYSIS;

EID: 1242297068     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(04)82020-2     Document Type: Article

References (54)

1. R. H. Thomson, "Naturally Occurring Quinones III. Recent Advances." Chapman & Hall, London, 1986.
2. J. A. Duke, "CRC Handbook of Medicinal Herbs." CRC Press, Boca Raton, 1985.
3. J. M. Watt and M. G. Breyer-Brandwijk, "The Medicinal and Poisonous Plants of Southern and Eastern Africa," Second Edition. Livingstone, Edinburgh, 1963.
4. G. R. Hughes, J. Soc. Cosmet. Chem. 10, 159 (1959).
5. M. E. Hanke and S. M. Talaat, Trans. Roy. Soc. Trop. Med. Hyg. 55, 56 (1961).
6. M. Krishnaswamy and K. K. Purushothaman, Ind. J. Exp. Biol. 18, 876 (1980).
7. R. V. Rao, T. J. McBride, and J. J. Oleson, Cancer Res. 28, 1952 (1968).
8. V. K. Tandon, M. Vaish, J. M. Khanna, and N. Anand, Arch. Pharm. (Weinhiem) 323, 383 (1990).
9. A. B. Pardee, Y. Z. Lee, and C. J. Lee, Curr. Cancer Drug Targets 2, 227 (2002).
10. P. Buc Calderon, J. Cadrobbi, C. Marques, N. Hong-Ngoe, J. M. Jamison, J. Gilloteaux, J. L. Summers, and H. S. Taper, Curr. Med. Chem. 9, 2271 (2002).
11. A. Brunmark and E. Cadenas, Free Rad. Biol. Med. 7, 435 (1989).
12. K. Öllinger and A. Brunmark, J. Biol. Chem. 266, 21496 (1991).
13. G. Powis, Pharmacol. Ther. 35, 57 (1987).
14. L. Ernster, Meth. Enzymol. 10, 309 (1967).
15. C. Lind, P. Hochstein, and L. Ernster, Arch. Biochem. Biophys. 216, 178 (1982).
16. C. Lind, E. Cadenas, P. Hochstein, and L. Ernster, Meth. Enzymol. 186, 287 (1990).
17. R. Munday, Free Rad. Res. 32, 245 (2000).
18. R. Munday, Redox Rep. 3, 189 (1997).
19. R. Munday, Free Rad. Res. 35, 145 (2001).
20. R. Munday, Free Rad. Biol. Med. 26, 1475 (1999).
21. R. Munday, Free Rad. Biol. Med. 22, 689 (1997).
22. G. D. Buffinton, K. Öllinger, A. Brunmark, and E. Cadenas, Biochem. J. 257, 561 (1989).
23. E. Cadenas, Biochem. Pharmacol. 49, 127 (1995).
24. R. Munday, unpublished observation.
25. E. Cadenas, D. Mira, A. Brunmark, C. Lind, J. Segura-Aguilar, and L. Ernster, Free Rad. Biol. Med. 5, 71 (1988).
26. T. Ishii and I. Fridovich, Free Rad. Biol. Med. 8, 21 (1990).
27. P. Eyer, Chem.-Biol. Interact. 80, 159 (1991).
28. B. Bandy, J. Moon, and A. J. Davison, Free Rad. Biol. Med. 9, 143 (1990).
29. D. Ross, J. K. Kepa, S. L. Winski, H. D. Beall, A. Anwar, and D. Siegel, Chem.-Biol. Interact. 129, 77 (2000).
30. P. L. Gutierrez, Free Rad. Biol. Med. 29, 263 (2000).
31. T.-J. Chiou and W.-F. Tzeng, Toxicology 154, 75 (2000).
32. P. Joseph, D. J. Long, A. J. P. Klein-Szanto, and A. K. Jaiswal, Biochem. Pharmacol. 60, 207 (2000).
33. R. M. Phillips, Biochem. Pharmacol. 58, 303 (1999).
34. L. M. Nutter, E. O. Ngo, G. R. Fisher, and P. L. Gutierrez, J. Biol. Chem. 267, 2474 (1992).
35. G. Powis, P. Y. Gasdaska, A. Gallegos, K. Sherrill, and D. Goodman, Anticancer Res. 15, 1141 (1995).
36. J. M. Karczewski, J. G. P. Peters, and J. Noordhoek, Biochem. Pharmacol. 57, 27 (1999).
37. D. Ross, H. Thor, M. D. Threadgill, M. S. Sandy, M. T. Smith, P. Moldéus, and S. Orrenius, Arch. Biochem. Biophys. 248, 460 (1986).
38. M. G. Miller, A. Rodgers, and G. M. Cohen, Biochem. Pharmacol. 35, 1177 (1986).
39. A. Halinska, T. Belej, and P. J. O'Brien, Br. J. Cancer 74 (Suppl. 27), S23 (1996).
40. H. Babich and A. Stern, J. Appl. Toxicol. 13, 353 (1993).
41. H. D. Beall, R. T. Mulcahy, D. Siegel, R. D. Traver, N. W. Gibson, and D. Ross, Cancer Res. 54, 3196 (1994).
42. H. D. Beall, Y. Liu, D. Siegel, E. M. Bolton, N. W. Gibson, and D. Ross, Biochem. Pharmacol. 51, 645 (1996).
43. S. Y. Sharp, L. R. Kelland, M. R. Valenti, L. A. Brunton, S. Hobbs, and P. Workman, Mol. Pharmacol. 58, 1146 (2000).
44. R. Munday, E. A. Fowke, B. L. Smith, and C. M. Munday, Free Rad. Biol. Med. 16, 725 (1994).
45. R. Munday, B. L. Smith, and C. M. Munday, Free Rad. Biol. Med. 19, 759 (1995).
46. R. Munday, B. L. Smith, and E. A. Fowke, J. Appl. Toxicol. 11, 85 (1991).
47. R. Munday, B. L. Smith, and C. M. Munday, Chem.-Biol. Interact. 98, 185 (1995).
48. R. Munday, B. L. Smith, and C. M. Munday, manuscript in preparation.
49. R. Munday, B. L. Smith, and C. M. Munday, Chem.-Biol. Interact. 108, 155 (1998).
50. R. Munday, B. L. Smith, and C. M. Munday, Chem.-Biol. Interact. 134, 87 (2001).
51. R. Munday, B. L. Smith, and C. M. Munday, Chem.-Biol. Interact. 123, 219 (1999).
52. V. Radjendirane, P. Joseph, Y.-H. Lee, S. Kimura, A. J. P. Klein-Szanto, F. J. Gonzalez, and A. K. Jaiswal, J. Biol. Chem. 273, 7382 (1998).
53. R. Munday, B. L. Smith, and C. M. Munday, Chem.-Biol. Interact. 117, 241 (1999).
54. R. J. Riley and P. Workman, Biochem. Pharmacol. 43, 1657 (1992).